Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients-Reference-Cited by-同舟云学术

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients

Published:2019-08-31 Issue:2 Volume:47 Page:292-303
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Jang Hyemin,Kim Hee Jin,Park Seongbeom,Park Yu Hyun,Choe Yeongsim,Cho Hanna,Lyoo Chul Hyoung,Yoon Uicheul,Lee Jin San,Kim Yeshin,Kim Seung Joo,Kim Jun Pyo,Jung Young Hee,Ryu Young Hoon,Choi Jae Yong,Moon Seung Hwan,Seong Joon-Kyung,DeCarli Charles,Weiner Michael W.,Lockhart Samuel N.,Cho Soo Hyun,Na Duk L.,Seo Sang Won^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04498-y.pdf

Reference43 articles.

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.

2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer Dement. 2011;7:263–269.

3. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer Dement. 2011;7:280–92.

4. Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62.

5. Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539–47.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular cognitive impairment: Advances in clinical research and management;Chinese Medical Journal;2024-07-24

2. Alzheimer’s disease and neurodegeneration in symptomatic cerebral small vessel disease;2024-05-20

3. Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study;Alzheimer's & Dementia;2024-04-27

4. Distinct spatiotemporal patterns of cortical thinning in Alzheimer’s disease-type cognitive impairment and subcortical vascular cognitive impairment;Communications Biology;2024-02-17

5. Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment;Neurology;2024-01-09